Your browser doesn't support javascript.
loading
Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
Stockler, Martin R; Martin, Andrew J; Davis, Ian D; Dhillon, Haryana M; Begbie, Stephen D; Chi, Kim N; Chowdhury, Simon; Coskinas, Xanthi; Frydenberg, Mark; Hague, Wendy E; Horvath, Lisa G; Joshua, Anthony M; Lawrence, Nicola J; Marx, Gavin M; McCaffrey, John; McDermott, Ray; McJannett, Margaret; North, Scott A; Parnis, Francis; Parulekar, Wendy R; Pook, David W; Reaume, M Neil; Sandhu, Shahneen; Tan, Alvin; Tan, Thean Hsiang; Thomson, Alastair; Vera-Badillo, Francisco; Williams, Scott G; Winter, Diana G; Yip, Sonia; Zhang, Alison Y; Zielinski, Robert R; Sweeney, Christopher J.
Affiliation
  • Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Martin AJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Davis ID; Monash University, Melbourne, Victoria, Australia.
  • Dhillon HM; CEMPED: The University of Sydney Centre for Medical Psychology and Evidence-Based Decision-Making, Sydney, NSW, Australia.
  • Begbie SD; Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia.
  • Chi KN; BC Cancer Agency Vancouver Centre, Vancouver, BC, Canada.
  • Chowdhury S; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Coskinas X; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Frydenberg M; Monash University, Melbourne, Victoria, Australia.
  • Hague WE; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Horvath LG; Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
  • Joshua AM; Kinghorn Cancer Centre, St Vincent's Hospital, Sydney, New South Wales, Australia.
  • Lawrence NJ; Auckland District Health Board, Auckland, New Zealand.
  • Marx GM; Sydney Adventist Hospital, Sydney, NSW, Australia.
  • McCaffrey J; Cancer Trials Ireland, Dublin, Ireland.
  • McDermott R; St Vincent's University Hospital, Dublin, Ireland.
  • McJannett M; ANZUP Cancer Trials Groups, Sydney, NSW, Australia.
  • North SA; Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Parnis F; Adelaide Cancer Centre, Adelaide, South Australia, Australia.
  • Parulekar WR; Canadian Cancer Trials Group, Kingston, Ontario, Canada.
  • Pook DW; Monash Health, Melbourne, Victoria, Australia.
  • Reaume MN; University of Ottawa, Ottawa, Ontario, Canada.
  • Sandhu S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Tan A; Waikato District Health Board, Hamilton, New Zealand.
  • Tan TH; Royal Adelaide Hospital, Adelaide, South Australia, Australia.
  • Thomson A; Royal Cornwall Hospital, Cornwall, United Kingdom.
  • Vera-Badillo F; Kingston Health Sciences Centre, Kingston, Ontario, Canada.
  • Williams SG; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Winter DG; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Yip S; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Zhang AY; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
  • Zielinski RR; Orange Health Service, Orange, New South Wales, Australia.
  • Sweeney CJ; Dana-Farber Cancer Institute, Boston, MA.
J Clin Oncol ; 40(8): 837-846, 2022 03 10.
Article in En | MEDLINE | ID: mdl-34928708

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Quality of Life / Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Quality of Life / Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: J Clin Oncol Year: 2022 Document type: Article